Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

CNS tumours

796 - Strategic planning and teamwork key to immediate minimal side effects and early good outcome of stereotactic radiosurgery and radiotherapy in patients with vestibular schwannoma; the National Cancer Institute Putrajaya Experience


19 Dec 2015


CNS tumours


Mohamed Amin Mohamed Ali


Annals of Oncology (2015) 26 (suppl_9): 34-36. 10.1093/annonc/mdv520


M.A. Mohamed Ali1, A.Z. Abdul Latif2, Y. Yusoff1, M.F. Jaffar1, H.K. Sudarshan Singh3, N. Abdullah1

Author affiliations

  • 1 Radiotherapy & Oncology, National Cancer Institute, Precint 7 - Putrajaya/MY
  • 2 Faculty Of Medicine, Universiti Sultan Zainal Abidin, 20400 - Kuala Terengganu/MY
  • 3 Radiology, National Cancer Institute, Precint 7 - Putrajaya/MY

Abstract 796


To evaluate the feasibility and early side effects of patients with vestibular schwannoma (VS) treated with stereotactic radiosurgery (SRS) and radiotherapy (SRT) in National Cancer Institute, Putrajaya in 2014


This study is based on an analysis of 14 patients with VS treated with stereotactic radiosurgery or radiotherapy in a newly setup cancer center in 2014 using a LINAC-based radiotherapy machine. Patients selection was done by a team of clinical oncologists, neurosurgeons and radiologists during tumour board meetings. All patients underwent pure tone audiometry, MR imaging and CT simulation planning sessions where these images were fused and treatment planning were done. A customised immobilisation device was fabricated during the CT simulation planning session using a frameless stereotactic mask system. 57% (n = 8) had SRS (12 Gy in single fraction) and 43% had hypofractionated SRT (35Gy in 7 fractions) as primary treatment. During treatment verification, image guidance consisting of dual in-room kV x-ray, two infrared cameras and 6D robotic couch patients positioning were used. The patients were then seen in clinic at six weeks post treatment to assess early side effects following which 6 monthly clinical and radiological assessments were done using MR imaging.


Both treatment modalities were well tolerated. Median follow-up time was 9 months. 29% (n = 4) experienced worsening headache (Grade 1 n = 2, Grade 2 n = 2) during 1st follow-up. At 6 months follow up, symptoms of headache were well controlled after conservative management and MR imaging showed stable disease in all patients.


This study showed that, with respect to early toxicity, SRS and SRT for patients with vestibular schwannoma showed to be a feasible and safe technique of treatment modality. However meticulous preparation from well trained staff, good teamwork between departments, sophisticated radiotherapy treatment machines, good quality control and assurance plays a major role behind the setup of this treatment modality.

Clinical trial identification


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings